Taysha Gene Therapies
TSHA
#6550
Rank
HK$5.48 B
Marketcap
HK$20.96
Share price
0.75%
Change (1 day)
17.17%
Change (1 year)

Taysha Gene Therapies (TSHA) - Total debt

Total debt on the balance sheet as of March 2025 : HK$0.48 Billion

According to Taysha Gene Therapies's latest financial reports the company's total debt is HK$0.48 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Taysha Gene Therapies - Total debt on balance sheet (from 2020 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.49 B2.78%
2023-12-31HK$0.47 B1.93%
2022-12-31HK$0.46 B-4.82%
2021-12-31HK$0.49 B
2020-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$25.21 M-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA